ENZ News Alert Enzo Biochem (ENZ) 4.51 12/25/2014 10:35:17

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Enzo Biochem (ENZ) 4.51 $ENZ

Enzo Biochem's (ENZ) Management on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Dec 10, 12:13PM CST

ENZ: 4.51 (+0.09)

Enzo Biochem ups revenues 3% in FQ1
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 6:35AM CST

ENZ: 4.51 (+0.09)

Enzo Biochem EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 3:59PM CST

ENZ: 4.51 (+0.09)

Enzo Biochem reports 1Q loss
Automated Insights - Tue Dec 09, 3:21PM CST
FARMINGDALE, N.Y. (AP) _ Enzo Biochem Inc. (ENZ) on Tuesday reported a loss of $3.7 million, or 8 cents per share, in its fiscal first quarter.
ENZ: 4.51 (+0.09)

Enzo Biochem Reports Strong Fiscal First Quarter Results
Business Wire - Tue Dec 09, 3:15PM CST
Enzo Biochem, Inc. (NYSE: ENZ) today reported strong operating results for the fiscal first quarter ended October 31, 2014.
ENZ: 4.51 (+0.09)

Enzo reports December 10
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 3:30PM CST

ENZ: 4.51 (+0.09)

Enzo Biochem Schedules Teleconference to Discuss First Quarter Results Wednesday, December 10, 2014 at 8:30 AM E.T.
Business Wire - Wed Dec 03, 9:00AM CST
Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2015 first quarter results, Wednesday, December 10, 2014, at 8:30 AM E.T.
ENZ: 4.51 (+0.09)

2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Nov 24, 10:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/swvhm8/20142014_uk) has announced the addition of the "2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Key Topics Covered: - INTRODUCTION - HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW - UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES - POTENTIAL MARKET ENTRY BARRIERS AND RISKS - COMPETITIVE ASSESSMENTS - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/sw...0142014_uk
SQNM: 3.59 (-0.01), ENZ: 4.51 (+0.09), CPHD: 53.39 (+0.51), DHR: 86.79 (-0.27), HOLX: 26.89 (+0.10), NVS: 93.91 (+0.66)

Enzo Biochem (ENZ) in Focus: Stock Moves 6.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 24, 8:25AM CST
Enzo Biochem (ENZ) was a big mover last session, with shares rising nearly 7% on the day.
BIIB: 340.89 (+5.13), ENZ: 4.51 (+0.09), AMAG: 43.02 (+0.90), AFFX: 9.80 (+0.05)

What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:57AM CDT
Enzo Biochem stock could bring additional losses for your portfolio
HALO: 9.34 (+0.31), EBS: 27.64 (+1.28), ENZ: 4.51 (+0.09), EPZM: 17.71 (+0.01)

Enzo Biochem Reports Strong Fiscal Fourth Quarter Results
Business Wire - Thu Oct 09, 3:15PM CDT
Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fourth quarter and fiscal year ended July 31, 2014, with continued solid year-end gains posted by both Life Sciences and Clinical Labs.
ENZ: 4.51 (+0.09)

Enzo Biochem wins novel vectors patent for gene therapy treatments in the US
M2 - Wed Oct 08, 7:58AM CDT
Molecular diagnostics company Enzo Biochem (NYSE:ENZ) reported on Tuesday the receipt of the patent for novel vectors for gene therapy treatments for cancers, virus infections and genetic diseases in the US.
ENZ: 4.51 (+0.09)

Enzo Biochem Awarded Patent for Novel Vectors Involving Gene Therapy Treatments for Cancer, Virus Infections and Genetic Diseases
Business Wire - Tue Oct 07, 8:02AM CDT
Enzo Biochem, Inc. (NYSE:ENZ) today announced that the U.S. Patent and Trademark Office has awarded the Company Patent No. 8,846,893, covering novel vectors for gene therapy treatments for cancers, virus infections and genetic diseases.
ENZ: 4.51 (+0.09)

Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter Results Friday, October 10, 2014 at 8:30 AM E.T.
Business Wire - Mon Oct 06, 9:00AM CDT
Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2014 fourth quarter results, Friday, October 10, 2014, at 8:30 AM E.T.
ENZ: 4.51 (+0.09)

UK Major Infectious Disease Testing Product Suppliers by Assay and Country 2014
M2 - Thu Oct 02, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rjvfjn/uk_sales_and) has announced the addition of the "UK Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country" report to their offering. This unique report provides UK sales and market share estimates for major suppliers of infectious disease testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. List of Tables - U.K. AIDS Testing Market Diagnostics Sales by Major Supplier - U.K. Campylobacter Testing Market Diagnostics Sales by Major Supplier - U.K. Candida Testing Market Diagnostics Sales by Major Supplier - U.K. Gonorrhea Testing Market Diagnostics Sales by Major Supplier - U.K. Hepatitis Testing Market Diagnostics Sales by Major Supplier - U.K. Hepatitis C Testing Market Diagnostics Sales by Major Supplier - U.K. Influenza Testing Market Diagnostics Sales by Major Supplier - U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier - U.K. Pneumonia Testing Market Diagnostics Sales by Major Supplier - U.K. RSV Testing Market Diagnostics Sales by Major Supplier - U.K. Rubella Testing Market Diagnostics Sales by Major Supplier - U.K. Septicemia Testing Market Diagnostics Sales by Major Supplier - U.K. Shigella Testing Market Diagnostics Sales by Major Supplier - U.K. Streptococci Testing Market Diagnostics Sales by Major Supplier - U.K. Syphilis Testing Market Diagnostics Sales by Major Supplier - U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - Biomerieux - Bio-Rad - Cepheid - Diamedix - Diasorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Grifols/Novartis Diagnostics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Lonza - Nanogen/Elitech - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - ThermoFisher/Life Technologies - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/rj..._sales_and
SQNM: 3.59 (-0.01), ENZ: 4.51 (+0.09), CPHD: 53.39 (+0.51), DHR: 86.79 (-0.27), HOLX: 26.89 (+0.10), NVS: 93.91 (+0.66)

2014 UK Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
M2 - Thu Oct 02, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vjh39d/uk_sales_and) has announced the addition of the "UK Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country" report to their offering. This unique report provides UK sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. List of Tables - U.K., Total Tumor Marker Sales by Major Supplier - U.K., CEA Testing Market Diagnostics - Sales by Major Supplier - U.K., PSA Testing Market Diagnostics - Sales by Major Supplier Companies Mentioned: - Abbott - AdnaGen - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - Correlogic Systems/Vermillion - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Epigenomics - Enterix - Enzo Biochem - Quest Diagnostics - Radient Pharmaceuticals - Roche - Siemens Healthcare - Takara Bio - Thermo Fisher/Life Technologies - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/vj..._sales_and
ENZ: 4.51 (+0.09), A: 41.13 (-0.24), DGX: 67.94 (-0.16), DHR: 86.79 (-0.27)

US Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
M2 - Tue Sep 30, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nqkj8f/us_sales_and) has announced the addition of the "US Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country" report to their offering. This unique report provides US sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Mentioned: Partial List - Diagnocure - Diasorin - Eiken Chemical - Epigenomics - Enterix - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Guided Therapeutics - Hologic/Gen-Probe - Kreatech - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen/Ipsogen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio For more information visit http://www.researchandmarkets.com/research/nq..._sales_and
SQNM: 3.59 (-0.01), MYGN: 36.50 (+0.28), ENZ: 4.51 (+0.09), DGX: 67.94 (-0.16), HOLX: 26.89 (+0.10)

Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
M2 - Tue Sep 30, 5:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwszsk/sales_and_market) has announced the addition of the "Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country" report to their offering. This new report provides sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Featured (Partial List) - Abbott - AdnaGen - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode - Diadexus - Diagnocure - DiaSorin - Eiken Chemical - Epigenomics - Enterix - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Guided Therapeutics - Hologic/Gen-Probe - Kreatech - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech For more information visit http://www.researchandmarkets.com/research/mw...and_market
MYGN: 36.50 (+0.28), ENZ: 4.51 (+0.09), A: 41.13 (-0.24), CPHD: 53.39 (+0.51), DHR: 86.79 (-0.27), HOLX: 26.89 (+0.10)

Spain Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country 2014
M2 - Wed Sep 24, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pzjt3v/spain_sales_and) has announced the addition of the "Spain Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country" report to their offering. This unique report provides Spain sales and market share estimates for major suppliers of infectious disease testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - Biomerieux - Bio-Rad - Cepheid - Diamedix - Diasorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Grifols/Novartis Diagnostics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Lonza - Nanogen/Elitech - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - ThermoFisher/Life Technologies - Wallac/PE - Wako Key Topics Covered: List of Tables - AIDS Testing Market Diagnostics Sales by Major Supplier - Western Blot Testing Market Diagnostics Sales by Major Supplier - Chlamydia Testing Market Diagnostics Sales by Major Supplier - CMV Testing Market Diagnostics Sales by Major Supplier - Gonorrhea Testing Market Diagnostics Sales by Major Supplier - Hepatitis Testing Market Diagnostics Sales by Major Supplier - Hepatitis C Testing Market Diagnostics Sales by Major Supplier - Herpes Testing Market Diagnostics Sales by Major Supplier - Influenza Testing Market Diagnostics Sales by Major Supplier - Lyme Disease Testing Market Diagnostics Sales by Major Supplier - Meningitis Testing Market Diagnostics Sales by Major Supplier - Mononucleosis Testing Market Diagnostics Sales by Major Supplier - Mycoplasma Testing Market Diagnostics Sales by Major Supplier - RSV Testing Market Diagnostics Sales by Major Supplier - Rotavirus Testing Market Diagnostics Sales by Major Supplier - Rubella Testing Market Diagnostics Sales by Major Supplier - Septicemia Testing Market Diagnostics Sales by Major Supplier - Streptococci Testing Market Diagnostics Sales by Major Supplier - Syphilis Testing Market Diagnostics Sales by Major Supplier - Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier - Trichomonas Testing Market Diagnostics Sales by Major Supplier - Tuberculosis Testing Market Diagnostics Sales by Major Supplier For more information visit http://www.researchandmarkets.com/research/pz..._sales_and
SQNM: 3.59 (-0.01), ENZ: 4.51 (+0.09), CPHD: 53.39 (+0.51), DHR: 86.79 (-0.27), HOLX: 26.89 (+0.10), NVS: 93.91 (+0.66)

France Sales and Market Shares of Major Infectious Disease Testing 2014 - Product Suppliers by Assay and Country
M2 - Wed Sep 24, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6mqngv/france_sales_and) has announced the addition of the "France Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country" report to their offering. This unique report provides France sales and market share estimates for major suppliers of infectious disease testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - Biomerieux - Bio-Rad - Cepheid - Diamedix - Diasorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Grifols/Novartis Diagnostics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Lonza - Nanogen/Elitech - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - ThermoFisher/Life Technologies - Wallac/PE - Wako List of Tables - France AIDS Testing Market Diagnostics Sales by Major Supplier - France Adenovirus Testing Market Diagnostics Sales by Major Supplier - France Campylobacter Testing Market Diagnostics Sales by Major Supplier - France Candida Testing Market Diagnostics Sales by Major Supplier - France Chlamydia Testing Market Diagnostics Sales by Major Supplier - France CMV Testing Market Diagnostics Sales by Major Supplier - France Gonorrhea Testing Market Diagnostics Sales by Major Supplier - France Hepatitis Testing Market Diagnostics Sales by Major Supplier - France Hepatitis C Testing Market Diagnostics Sales by Major Supplier - France Herpes Testing Market Diagnostics Sales by Major Supplier - France Lyme Disease Testing Market Diagnostics Sales by Major Supplier - France Influenza Testing Market Diagnostics Sales by Major Supplier - France Meningitis Testing Market Diagnostics Sales by Major Supplier - France Mononucleosis Testing Market Diagnostics Sales by Major Supplier - France Mumps Testing Market Diagnostics Sales by Major Supplier - France Mycoplasma Testing Market Diagnostics Sales by Major Supplier - France RSV Testing Market Diagnostics Sales by Major Supplier - France Rotavirus Testing Market Diagnostics Sales by Major Supplier - France Rubella Testing Market Diagnostics Sales by Major Supplier - France Septicemia Testing Market Diagnostics Sales by Major Supplier - France Shigella Testing Market Diagnostics Sales by Major Supplier - France Streptococci Testing Market Diagnostics Sales by Major Supplier - France Syphilis Testing Market Diagnostics Sales by Major Supplier - France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier - France Trichomonas Testing Market Diagnostics Sales by Major Supplier - France Tuberculosis Testing Market Diagnostics Sales by Major Supplier For more information visit http://www.researchandmarkets.com/research/6m..._sales_and
SQNM: 3.59 (-0.01), ENZ: 4.51 (+0.09), CPHD: 53.39 (+0.51), DHR: 86.79 (-0.27), HOLX: 26.89 (+0.10), NVS: 93.91 (+0.66)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Governance Is Becoming Enterprise Infrastructure

Updated Category News Views 69

Governance Has Finally Reached the Engine Room Enterprise AI is no longer a shiny pilot parked in some innovation lab; it is creeping into business-critical work, and that changes the argument entirely. Frost & Sullivan’s latest analysis makes a sensible point that too many executives still resist: AI governance is becoming a strategic operating capability, not merely a...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 95

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 108

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 90

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 71

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 80

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 73

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading

Top 5 Most Recently Viewed Articles

An In-Depth Analysis of Qorvo's Current Short Interest Trends

Updated Category News Views 215

Understanding Qorvo's Short Interest Movement Qorvo Inc. (NASDAQ: QRVO) has been experiencing notable changes in its short interest, with a recent report indicating a decrease of 16.17%. This drop reflects a total of 5.20 million shares sold short, equating to about 7.67% of the total shares available for trading. Traders should note that, with the current trading volume,...

Continue Reading
Sev1Tech Secures $188M Contract with U.S. Space Force

Updated Category News Views 167

Sev1Tech Secures a Major Contract with the U.S. Space Force Sev1Tech has recently made headlines by being awarded a substantial contract valued at $188 million from the U.S. Space Force (USSF), specifically under the Space Systems Command (SSC). This contract involves expanding the support for an innovative and powerful network known as meshONE-T. This network is...

Continue Reading
Exploring Rigetti Computing's Growth and ETF Impact

Updated Category News Views 339

Understanding the Surge of Rigetti Computing Rigetti Computing Inc. (NASDAQ: RGTI) has seen an extraordinary performance recently, with its shares rising a staggering 100% year-to-date, and almost 3,900% over the past year. This impressive increase has attracted considerable investor interest, particularly from those focused on opportunities in the rapidly evolving...

Continue Reading
Kratos Defense Stock Climbs High: What Investors Should Know

Updated Category News Views 198

Kratos Defense Stock Reaches New Heights Kratos Defense (NASDAQ: KTOS) has recently achieved a remarkable milestone by hitting a 52-week high of $30.42. This achievement comes amid a strong defense market, marking a significant increase in the company's stock value with a one-year growth of 55.96%. Investors demonstrate growing confidence in Kratos, renowned for its...

Continue Reading
Precision Linear Actuators for Optical and Automation Needs

Updated Category News Views 143

High-Precision Micro-Positioning Solutions Available For those seeking reliability and accuracy in optical alignment, precision automation, and research applications, the latest offerings from PI deliver exceptional results. Introducing the L-220 Series Linear Actuators PI’s L-220 series linear actuators are designed for applications demanding sub-micrometer precision....

Continue Reading